![]() Molecular Partners Molecular Partners is a company that develops biopharmaceutical products for serious diseases. | ![]() Brii Biosciences Brii Biosciences researches and develops medicines for the treatment of chronic illnesses with significant burdens, including infectious diseases, liver and lung diseases, and other illnesses. | ![]() Thor Medical Thor Medical (formerly known as Nordic Nanovector) is a biopharmaceutical company that focuses on the development and commercialisation of novel targeted therapeutics in haematology and oncology. | ![]() Abliva Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease. | |
Founding Date | Founding Date 2004 | Founding Date 2018 | Founding Date 2009 | Founding Date 2000 |
Type | Type Public | Type Private | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Zürich-Schlieren, CH HQ Cambridge, US Concord, US | Locations CN HQ Beijing, CN Durham, US San Francisco, US San Mateo, US | Locations Oslo, NO HQ Zug, CH Shrewsbury, GB | Locations Lund, SE HQ |
Employees | Employees 158 | Employees 8510% decrease | Employees 3716% decrease | Employees 950% increase |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) kr439k (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit kr4.3m (FY, 2025) | Gross profit kr497k (FY, 2024) |
Net income | Net income (CHF61.7m) (FY, 2025) | Net income N/A | Net income (kr58m) (FY, 2025) | Net income (kr90m) (FY, 2024) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 415m | Total funding raised N/A | Total funding raised $ 10.8m |

Brii Biosciences researches and develops medicines for the treatment of chronic illnesses with significant burdens, including infectious diseases, liver and lung diseases, and other illnesses.
View company
Thor Medical (formerly known as Nordic Nanovector) is a biopharmaceutical company that focuses on the development and commercialisation of novel targeted therapeutics in haematology and oncology.
View company
Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease.
View company